Chemoinformaics analysis of Potassium isolespedezate
| Molecular Weight | 380.39 | nRot | 5 |
| Heavy Atom Molecular Weight | 363.254 | nRig | 14 |
| Exact Molecular Weight | 380.051 | nRing | 2 |
| Solubility: LogS | -0.385 | nHRing | 1 |
| Solubility: LogP | -1.414 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 6 |
| nHA | 9 | APOL | 86.6635 |
| nHD | 5 | BPOL | 22.2625 |
| QED | 0.283 |
| Synth | 4.069 |
| Natural Product Likeliness | 1.657 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.032 |
| HIA | 0.884 |
| CACO-2 | -5.936 |
| MDCK | 0.0000497 |
| BBB | 0.241 |
| PPB | 0.722616 |
| VDSS | 0.254 |
| FU | 0.291032 |
| CYP1A2-inh | 0.098 |
| CYP1A2-sub | 0.021 |
| CYP2c19-inh | 0.025 |
| CYP2c19-sub | 0.059 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.216 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.12 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.017 |
| CL | 1.668 |
| T12 | 0.925 |
| hERG | 0.064 |
| Ames | 0.04 |
| ROA | 0.079 |
| SkinSen | 0.642 |
| Carcinogencity | 0.28 |
| EI | 0.174 |
| Respiratory | 0.024 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.619217 |